HOME >> MEDICINE >> NEWS
NIEHS issues additional awards to continue 9/11 follow up

tion and Training Fund, National Puerto Rican Forum, Inc., and University of Medicine and Dentistry of New Jersey.

The purpose of these administrative supplements is to develop an integrated education and training approach that will address worker safety and immediate and long-term health concerns. These funds will support training of a nationwide cadre of environmental response workers to respond to future terrorist attacks, along with the creation of a national registry of trained construction personnel for immediate response to terrorist activities.

NIEHS responded to the needs of the New York City residents immediately after the 9/11 attack. Its Worker Education and Training Program delivered 3,000 respirators to the site and provided expert support to coordinate occupational health issues during recovery and cleanup. NIEHS-supported researchers were on-site collecting environmental and air samples the day after the disaster.

Since then the Institute has funded a multi-faceted array of studies on the health consequences of the attacks. NIEHS grantees have identified the composition and structure of dust particles from the collapse of the buildings, and have determined particle size and the degree of penetration into the airways of those who were exposed. Researchers have also created a public data base that includes both pre- and post-September 11 air quality data - the web address is http://wtc.hs.columbia.edu.

Other NIEHS-funded researchers have conducted clinical and epidemiological studies to investigate respiratory abnormalities and post-traumatic stress syndrome in WTC-exposed populations such as firefighters, ironworkers and community residents.

Scientists have also identified the symptoms and duration of the "World Trade Center Cough," and determined that most dust particles from the attacks were small enough to penetrate into lung airways, producing caustic
'"/>

Contact: Tom Hawkins
hawkins@niehs.nih.gov
919-541-1402
NIH/National Institute of Environmental Health Sciences
15-Oct-2003


Page: 1 2 3

Related medicine news :

1. NIEHS and American Public Health Association sponsor program
2. NIEHS announces $20 million, three-center effort to pin-point environmental triggers of Parkinsons
3. Studies address issues of risk and survival in rapidly increasing GI cancers
4. Hormone therapy controversy raises drug safety issues
5. How platelets help cancer invade other tissues
6. NIH panel issues State-of-the-Science statement on end-of-life care
7. Money issues leading cause of holiday stress for Americans
8. Developmental issues among triplet infants
9. Health issues may affect grandmothers who are primary caregivers
10. Exercise for special populations, sensory research, factors impacting rehabilitation top issues
11. Insulin-producing cells found in a variety of tissues in diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIEHS issues additional awards continue follow

(Date:11/22/2014)... 23, 2014 BambooFlooringChina.com is a ... has proudly released its new collection of bamboo mats ... up to 29% off. , According to the ... tree-like grass, making it a highly renewable resource. Their bamboo ... a mixing color which comes from natural bamboo with caramel ...
(Date:11/22/2014)... Setria® Glutathione is now available ... for use “as a therapeutically active ingredient in ... Therapeutic Goods (Listing) Notice 2014 (No. 5) - ... Glutathione will be exclusivity distributed in Australia by ... imports fine chemicals to Australian manufacturers. TGA approval ...
(Date:11/22/2014)... Discount-Dress.com is an important company in the dress industry. ... company’s online market share by a series of promotions. Recently, ... announced a bridesmaid dress promotion for the new year 2015. ... the dresses from this company are not only of high ... very good at manufacturing wedding dresses. Customers prefer to choose ...
(Date:11/22/2014)... November 22, 2014 Nocturia is ... the complaint that the individual has to wake ... The report “Nocturia – Pipeline Review, H2 2014” ... Nocturia, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:11/22/2014)... 22, 2014 A petition seeking a ... ) in minimally-invasive hysterectomies and fibroid removal surgeries ... end of October, Bernstein Liebhard LLP reports. According ... of November 21st, 2014. That represents an increase of ... signed on to the campaign.* , The campaign to ...
Breaking Medicine News(10 mins):Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Gains More than 450 Signatures Since October, Bernstein Liebhard LLP Reports 4
(Date:11/21/2014)... 21, 2014  World Hemp Oil, an importer of ... they are now offering legal, organic oil with high ... strains grown in medical marijuana states. People suffering from ... as Parkinson,s, MS, and spinal cord injury, no longer ... because imported CBD Oil Is legal in all states. ...
(Date:11/21/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... to acquire 100% of QCR & Trio Diagnostics Limited, ... organization. The transaction closed on November 17, 2014. ...
(Date:11/21/2014)... , 21. November 2014 /PRNewswire/ ... hat heute bekannt gegeben, dass die ... EMA) die Kennzeichnung als Orphan-Medizinprodukt an ... des Unternehmens zur Behandlung von Fibrodysplasia ... seltene, stark beeinträchtigende genetische Krankheit, die ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
Cached News: